Skip to main content
XENE logo

XENE · Xenon Pharmaceuticals Inc.

Track XENE — free
$62.35 -1.88 (-2.93%) At close · Aug 14
Market Cap
$6.04B
Shares
96.84M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-13 STEVEN GANNON 10,000
2026-06-05 GILLIAN CANNON 1,190
2026-06-05 GARY PATOU 1,322
2026-03-13 IAN MORTIMER 7,308
2026-03-13 ANDREA DIFABIO 1,342
2026-03-13 CHRISTOPHER JOHN KENNEY 1,410
2026-03-10 CHRISTOPHER JOHN KENNEY 2,771
2026-03-10 ANDREA DIFABIO 2,607
2026-03-10 IAN MORTIMER 11,269
2026-03-09 IAN MORTIMER 270,000
2026-01-02 IAN MORTIMER 40,000
2025-12-08 IAN MORTIMER 10,830
2025-12-05 IAN MORTIMER 14,375
2025-12-01 IAN MORTIMER 97
2025-10-01 IAN MORTIMER 25,000
2025-09-19 SHERRY AULIN 2,548
2025-01-27 IAN MORTIMER 16,315
2025-01-24 IAN MORTIMER 22,468
2025-01-23 IAN MORTIMER 16,217
2024-12-18 SHERRY AULIN 18,709
2024-11-22 GARY PATOU 4,891
2024-07-12 SIMON PIMSTONE 70,000
2024-06-12 ROBIN SHERRINGTON 60,000
2024-06-05 SIMON PIMSTONE 110,000
2024-03-08 ELIZABETH GAROFALO 2,092
2024-03-07 STEVEN GANNON 13,000
2024-03-07 ROBIN SHERRINGTON 7,137
2023-12-14 PATOU GARY 7,598
2023-12-13 GARY PATOU 11,380
2023-08-24 DAWN SVORONOS 25,000
2023-06-01 SIMON PIMSTONE 31,713
2023-05-31 SIMON PIMSTONE 12,000
2023-05-30 SIMON PIMSTONE 37,006
Showing 1–33 of 33 filings
Key facts CIK 1582313 CUSIP 98420N105 13F (30d) 307 filings 301 filers Visit website Investor relations